A Randomized, Double-Blind, Placebo-Controlled Study Evaluatig the Safety and Efficacy of Varenicline for Smoking Cessation in Patients with Schizophrenia or Schizoaffective Disorder
The Center of Excellence for Integrated Health Solutions provides resources, training and technical assistance to advance the integration of primary and behavioral health care.
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.